Becton Dickinson BDX beats Q3 2026 estimates, raises full-year EPS guidance
As seen on the 24/7 Wall St. homepage on August 6, 2026.
Management lifted the low end of full-year adjusted EPS guidance to a $12.62 to $12.72 range after the first full quarter as a standalone MedTech company, following February's Biosciences spin-off, landed ahead on both lines. GLP-1 demand for the Vystra injection pen drove the gain, with buybacks continuing.
Continue ReadingShow less
Becton Dickinson reported Q3 2026 adjusted EPS of $3.23, topping the $3.14 consensus estimate by about 2.9%. Revenue came in at $4.98 billion, clearing the $4.89 billion estimate by roughly 1.9%. The quarter marked the first full reporting period for BD as a standalone MedTech company after spinning off its Biosciences segment in February.
The standout growth driver was GLP-1 demand for the Vystra injection pen, which helped lift both the top and bottom lines. Share buybacks also contributed to the earnings beat. Off the stronger quarter, management raised the low end of its full-year adjusted EPS guidance, setting a new range of $12.62 to $12.72.
Disclosure
1 INVESTMENTS ARE NOT FDIC INSURED • ARE NOT BANK GUARANTEED • MAY LOSE VALUE Brokerage and Active investing products offered through SoFi Securities LLC, member FINRA( www.finra.org )/SIPC( www.sipc.org ). 2 The probability of a member receiving $3,000 is 0.028%. If you don’t make a selection in 45 days, you’ll no longer qualify for the promo. Members must fund their account with a minimum of $50.00 to qualify. The probability percentage is subject to decrease. Members are only eligible for the Stock Award promotion upon opening their first brokerage account; subsequent cash brokerage accounts are ineligible for the promo, including for members with multiple accounts. 3Other fees, such as exchange fees, may apply. Please view our fee disclosure to view a full listing of fees. 4There are limitations with fractional shares to consider before investing. During market hours fractional share orders are transmitted immediately in the order received. There may be system delays from receipt of your order until execution and market conditions may adversely impact execution prices. Outside of market hours orders are received on a not held basis and will be aggregated for each security then executed in the morning trade window of the next business day at market open. Share will be delivered at an average price received for executing the securities through a single batched order. Fractional shares may not be transferred to another firm. Fractional shares will be sold when a transfer or closure request is initiated. Please consider that selling securities is a taxable event.
SoFi Active Invest is offering a limited-time promotion. Open an account, fund it with $50 or more, and you could receive up to $3,000 in complimentary stock for Active Invest accounts. See for yourself by clicking here now. (Sponsor)
The EPS history shows a consistent pattern of beating estimates going back to Q3 2024, though the reported figures in Q1 and Q2 2026 reflect the post-spin-off structure of the business — making the Q3 2026 result the clearest apples-to-apples baseline for BD's new standalone profile. Investors will likely watch whether Vystra demand and buyback activity can sustain the upper end of that full-year guidance range.